Tech Company M&A Transactions
Adaptate Biotherapeutics Acquisition
Headquartered in London, Adaptate Biotherapeutics was bought by Takeda Pharmaceuticals. Takeda Pharmaceuticals did not announce the acquisition terms for the deal.
Transaction Overview
Company Name
Acquired By
Announced On
1/10/2022
Transaction Type
M&A
Amount
Unknown
M&A Terms
The acquisition of Adaptate is expected to be finalized in Q1 of Takeda's fiscal year 2022, pending completion of review under applicable antitrust laws, including the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 in the U.S.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
195 Wood Lane WestWorks, White City Place
London, W12 7FQ
UK
London, W12 7FQ
UK
Phone
Website
Email Address
Overview
Adaptate Biotherapeutics is developing therapeutic antibodies which harness the potential of patients' own gamma delta T cells in situ. Gamma delta T cells play a critical role in immune surveillance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Natalie Mount
Browse more venture capital transactions:
Prev: 1/8/2022: Ray Therapeutics venture capital transaction
Next: 1/11/2022: Swae venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs